Ostia Sciences joins forces with Lallemand Health Solutions’ Expert’Biome CDMO (contract development and manufacturing organization) to advance a novel oral probiotic into clinical trials. The ingredient, Streptococcus salivarius SALI-10 — a proprietary probiotic strain designed to support oral microbiome health — will be brought to industrial-scale production through the collaboration.
